Related Experiment Video
Updated: Aug 9, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Retrospective study on clinical features and risk factors of ventilator-associated pneumonia
Tieying Sun1, Yanming Li, Yunjian Hu
1Department of Respiratory Disease, Beijing Hospital, Beijing 100730, China Email suntieying@hotmail.com
Objective:
To deepen the understanding about ventilator-associated pneumonia (VAP).
Method:
Patients admitted to the respiratory intensive care unit from Jan 1996 approximately Oct 1999 were divided into two groups, with or without VAP, according to the diagnosis criteria. The comparative analysis was performed in clinical characteristics, risk factors, distribution of pathological organisms and prognosis.
Results:
The incidence of VAP was 48.3% (28/58 cases). The cases with deep venous catheter in VAP group were much more than non-VAP group P < 0.05 . The duration of ventilation >/= 20 days among the patients of VAP group was 32.1%,while it was 6.7% in non-VAP group. 53 microorganisms were isolated from 25 patients with VAP. The main pathogens were Acinetobacter spp (32.1%), P. Aeruginosa (20.8%) and C.albicans (22.6%). The mortality rate of VAP group was 32.1%, significantly higher than that of non-VAP group (P < 0.05).
Conclusions:
The risk factors of VAP may be the use of deep venous catheter and long duration of ventilation. The main pathogens were Acinetobacter species, Pseudomonas aeruginosa, and yeasts. The presence of VAP could significantly increase the mortality of patients.
Related Concept Videos
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction

